tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market

ImmunityBio (IBRX) Income Statement

Compare
1,693 Followers

ImmunityBio Income Statement

Last quarter (Q3 2025), ImmunityBio's total revenue was $32.06M, an increase of 425.07% from the same quarter last year. In Q3, ImmunityBio's net income was $-67.25M. See ImmunityBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.74M$ 622.00K$ 240.00K$ 934.00K$ 605.00K
Gross Profit
$ 14.74M$ 622.00K$ 240.00K$ 934.00K$ 605.00K
Operating Expenses
$ 358.93M$ 362.87M$ 351.54M$ 331.21M$ 221.49M
Depreciation and Amortization
$ 17.55M$ 18.51M$ 18.26M$ 14.24M$ 12.74M
EBITDA
$ -264.43M$ -478.66M$ -351.88M$ -320.75M$ -204.22M
Operating Income
$ -344.18M$ -362.25M$ -351.30M$ -330.28M$ -220.88M
Other Income/Expenses
$ -69.46M$ -221.64M$ -65.99M$ -19.56M$ -5.15M
Pretax Income
$ -413.64M$ -583.89M$ -417.29M$ -349.84M$ -226.03M
Net Income
$ -413.56M$ -583.20M$ -416.57M$ -346.79M$ -221.85M
Per Share Metrics
Basic EPS
$ -0.59$ -1.15$ -1.04$ -0.89$ -0.59
Diluted EPS
$ -0.62$ -1.15$ -1.04$ -0.89$ -0.59
Weighted Average Shares Outstanding
697.31M 508.64M 399.90M 389.23M 383.18M
Weighted Average Shares Outstanding (Diluted)
700.44M 508.64M 399.90M 389.23M 383.18M
Currency in USD

ImmunityBio Earnings and Revenue History